language_icon
EN
HI

Global Longlife Hospital and Research Share price

GLHRL

12.83

0.67 (-4.96%)
Last updated on 15 May, 2026 | 15:05 IST
Today's High

13.50

Today's Low

12.83

52 Week Low

11.60

52 Week High

33.02

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Global Longlife Hospital and Research Chart

Global Longlife Hospital and Research Share Key Metrics

Volume
85000.00
Market Cap
14.18 CR
LTQ@LTP
1000@12.83
ATP
12.98
Var Margin
100 %
Circuit Range
12.83-14.17
Delivery %
100 %
Value
11.03 L
ASM/GSM
No
Market Lot
1000

Summary

Global Longlife Hospital and Research share price is ₹12.83 as of 17 May, 2026. The stock Global Longlife Hospital and Research intraday movement has stayed between ₹12.83 and ₹13.50, while on a 52-week basis,Global Longlife Hospital and Research price 52 week high is ₹33.02 & its 52 week low is ₹11.60.
In terms of trading activity, Global Longlife Hospital and Research has recorded a volume of 85000 shares, The Global Longlife Hospital and Research has a market cap of ₹10500000 CR. The stock’s Average Traded Price (ATP) stands at ₹12.98, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1000 @ ₹12.83.
Global Longlife Hospital and Research operates within a circuit range of ₹12.83 – ₹14.17, with a Value of ₹11.03 L. The Delivery Percentage for the day is 100%. Additionally, Global Longlife Hospital and Research currently falls under the No framework, and trades with a market lot size of 1000.

Global Longlife Hospital and Research Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

56.28

Sector P/B

-15.69

Sec. Div. Yield

1.98

Global Longlife Hospital and Research Resistance and Support

Pivot 13.58

Resistance

First Resistance

13.66

Second Resistance

13.82

Third Resistance

13.9

Support

First Support

13.42

Second Support

13.34

Third Support

13.18

Global Longlife Hospital and Research Shareholding Pattern

View More
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

22.88%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

77.12%

Others

0%

Total Promoters
MAR '26
22.88%

Global Longlife Hospital and Research Corporate Actions

DateAgenda
2026-05-07Audited Results
2025-11-12Half Yearly Results
2025-04-28Audited Results

Global Longlife Hospital and Research News

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Consideration Of Audited Financial Results For The Half Year And Year Ended March 31, 2026 And Other Matters

Global Longlife Hospital & Research Board approved FY26 audited financial results, reporting a net loss of ₹1.72 crore. The company also proposed changing its name and altering its main object clause.
May 07 2026 15:05:00

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Half Year And Year Ended On March 31, 2026.

Global Longlife Hospital & Research's Board will hold a meeting on May 07, 2026, to review and approve the audited financial results for H2 and the full year ended March 31, 2026. The agenda also includes considering a change in the company's name and alteration of its Object Clause, both subject to necessary approvals.
Apr 30 2026 16:04:00

About Global Longlife Hospital and Research

NSE : 0  
BSE : 543520  
ISIN : INE0J2K01014  

The Company was originally incorporated as ?Global Longlife Hospital and Research Private Limited‘‘ as a private limited company under the provisions of Companies Act 1956 vide Certificate of Incorporation dated January 20 2012 bearing Corporate Identification Number U85110GJ2012PTC068700 issued by the Registrar of Companies Gujarat Dadra and Nagar Haveli. Subsequently the Company was converted in to a public limited Company pursuant to a special resolution passed by the shareholders at the EGM held on August 05 2021 and consequently the name of the Company was changed to ?Global Longlife Hospital and Research Limited? and a fresh certificate of incorporation was issued by the Registrar of Companies Ahmedabad dated August 312021. The CIN of the Company is U85110GJ2012PLC068700.Major Events :2016- The Company has received Leadership award of "Best emerging hospital of India" by The Associated Chambers of Commerce and Industry of India.2018- The Company has received "GLOBAL ACHIEVERS AWARDS for HEALTH EXCELLENCE" for outstanding achievement in Health and Social Services at 12th International Achievers on "Global Business Opportunities" Dubai UAE- Certificate of Recognition as ?Times Health Icon” by Times Health Icon 2018 - A Times Group Company2021- Certificate of Recognition as ?Most Trusted Hospital” by Times Healthcare Leaders Ahmedabad 2021 - A Times Group Company

Read More

Global Longlife Hospital and Research Management

NamePosition
Hetal ThakkarExecutive Director
Tanvi SolankiCompany Secretary & Compliance Officer
View More

Global Longlife Hospital and Research FAQs

The Buying Price of Global Longlife Hospital and Research share is 12.83 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Global Longlife Hospital and Research stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Global Longlife Hospital and Research, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Global Longlife Hospital and Research shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Global Longlife Hospital and Research shares is 0. Useful to assess the stock's value relative to its book value.

To assess Global Longlife Hospital and Research’s valuation compare Sector P/E, P/B which are 56.28 & -15.69 with sector averages, along with growth rates and financial metrics.

The Market Cap of Global Longlife Hospital and Research is 14.18 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Global Longlife Hospital and Research share price is 33.02 & 11.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Global Longlife Hospital and Research belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost